Doctors in China and the US have transfused antibodies from recovered patients directly into the blood of people with severe cases of COVID-19. Dr. Mario Ostrowski and his collaborators want to identify the genes that encode these antibodies and use them to mass produce lab-grown versions — to turn into a drug to treat the infection.